S.A. Mason’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Sell |
9,228
-400
| -4% | -$27.6K | 0.31% | 77 |
|
|
2025
Q1 | $669K | Sell |
9,628
-50
| -0.5% | -$3.47K | 0.35% | 70 |
|
|
2024
Q4 | $833K | Buy |
9,678
+50
| +0.5% | +$4.3K | 0.44% | 59 |
|
|
2024
Q3 | $1.15M | Hold |
9,628
| – | – | 0.61% | 43 |
|
|
2024
Q2 | $1.37M | Hold |
9,628
| – | – | 0.78% | 31 |
|
|
2024
Q1 | $1.24M | Buy |
9,628
+2,428
| +34% | +$312K | 0.74% | 37 |
|
|
2023
Q4 | $745K | Sell |
7,200
-300
| -4% | -$31K | 0.5% | 50 |
|
|
2023
Q3 | $682K | Hold |
7,500
| – | – | 0.49% | 54 |
|
|
2023
Q2 | $597K | Hold |
7,500
| – | – | 0.43% | 65 |
|
|
2023
Q1 | $597K | Hold |
7,500
| – | – | 0.43% | 65 |
|
|
2022
Q4 | $508K | Hold |
7,500
| – | – | 0.38% | 74 |
|
|
2022
Q3 | $374K | Hold |
7,500
| – | – | 0.3% | 96 |
|
|
2022
Q2 | $418K | Sell |
7,500
-300
| -4% | -$16.7K | 0.31% | 94 |
|
|
2022
Q1 | $433K | Buy |
+7,800
| New | +$433K | 0.27% | 97 |
|